MWNA
BIND

Marshall Wace North America’s BIND THERAPEUTICS INC BIND Stock Holding History

Marshall Wace North America’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$154K Buy
+10,200
New +$130K ﹤0.01% 656

Other funds holding BIND

EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Marshall Wace North America's BIND Position: Q4 2013 in Review

Marshall Wace North America opened a new position in BIND THERAPEUTICS INC (BIND) in Q4 2013: 10,200 shares worth $154K. The stake represents ﹤0.01% of the portfolio and ranks #656 among its holdings.

42 funds tracked by Wall St. Rank hold BIND as of Q4 2013.

  • Marshall Wace North America held 10,200 shares of BIND THERAPEUTICS INC worth $154K as of Q4 2013.
  • BIND THERAPEUTICS INC was a new Marshall Wace North America position in Q4 2013.
  • BIND THERAPEUTICS INC made up ﹤0.01% of Marshall Wace North America's portfolio in Q4 2013, its #656 holding.
  • 42 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q4 2013.

Based on Marshall Wace North America's 13F filing for Q4 2013, filed 14 Feb 2014.